Siemens Healthineers Supervisory Board

The following table provides an overview of the composition of the various Standing Committees of the Supervisory Board.

The Chairman’s Committee, which comprises the Chairman and Deputy Chairman of the Supervisory Board as well as one further representative elected by the Supervisory Board, makes proposals, in particular, regarding the appointment and dismissal of Managing Board members and handles contracts with members of the Managing Board. It decides whether to approve contracts and business transactions with Managing Board members and parties related to them.

Committee members:
Michael Sen (Chairman)
Dr. Norbert Gaus
Dr. Andreas C. Hoffmann

The Audit Committee comprises four Supervisory Board members elected by the Supervisory Board. According to the German Stock Corporation Act, the Audit Committee must include at least one Supervisory Board member with knowledge and experience in the application of accounting principles or the auditing of financial statements. The Audit Committee oversees, in particular, the accounting process and conducts a preliminary review of the Annual Financial Statements of Siemens Healthineers AG, the Consolidated Financial Statements of the Siemens Healthineers Group and the Management Report. On the basis of the independent auditors’ report on their audit of the annual financial statements, the Audit Committee makes, after its preliminary review, recommendations regarding Supervisory Board approval of the Annual Financial Statements of Siemens Healthineers AG and the Consolidated Financial Statements of the Siemens Healthineers Group. In addition to the work performed by the independent auditors, the Audit Committee discusses the Company’s quarterly financial statements and half-year financial reports, which are prepared by the Managing Board. It concerns itself with the Company’s risk monitoring system and oversees the effectiveness of the internal control system as this relates, in particular, to financial reporting, the risk management system and the internal audit system. It prepares the Supervisory Board’s recommendation to the Annual Shareholders’ Meeting concerning the election of the independent auditors and submits the corresponding proposal to the Supervisory Board. It awards the audit contract to the independent auditors elected by the Annual Shareholders’ Meeting and monitors the independent audit of the financial statements – including, in particular, the auditors’ independence, professional expertise and services.

Commitee members:
Dr. Ralf P. Thomas (Chairman)
Michael Sen
Dr. Marion Helmes
Dr. Andreas C. Hoffmann

The Innovation and Finance Committee comprises the Chairman of the Supervisory Board, his Deputy and two further supervisory Board members elected by the Supervisory Board. Based on the Company’s overall strategy, the Committee discusses, in particular, the Company´s focuses of innovation and prepares the Supervisory Board´s discussions and resolutions regarding questions relating to the Company’s financial situation and structure ‒ including the annual planning (budget) ‒ as well as the Company’s fixed asset investments and its financial measures. In addition, the Innovation and Finance Committee has been authorized by the Supervisory Board to decide on the approval of transactions and measures that require Supervisory Board approval and have a value of less than €300 million.

Commitee members:
Michael Sen (Chairman)
Dr. Norbert Gaus
Dr. Gregory Sorensen
Karl-Heinz Streibich